Prime Highlights:
Yamaha Motor will debut the CELL HANDLER™ 2 at SLAS2025 in San Diego, USA, from January 27 to January 29, 2025.
The CELL HANDLER 2 is a cutting-edge cell picking and imaging system designed for high-speed, high-accuracy handling and data acquisition of cells and clusters.
Yamaha’s collaboration with HUB Organoids and MIMETAS will feature joint research presentations at the event.
Key Background:
Yamaha Motor Co., Ltd. has announced that it will unveil its latest innovation, the CELL HANDLER 2, at SLAS2025, one of the world’s premier exhibitions dedicated to life sciences and drug discovery automation. The event will take place in San Diego, USA, from January 27 to January 29, 2025. This marks the first international exhibition for the CELL HANDLER 2, a sophisticated cell handling and imaging system designed to enhance research in the life sciences sector.
SLAS2025 is a significant gathering for global research institutions and companies involved in laboratory automation, with a particular focus on cell research and drug discovery. During the exhibition, Yamaha will demonstrate the capabilities of the CELL HANDLER™ 2, showcasing its advanced functionality in cell picking, imaging, and data acquisition. This system has been developed to support high-speed, high-accuracy handling of both single cells and cell clusters, such as spheroids and organoids, which are pivotal in drug discovery research.
In addition to the product showcase, Yamaha Motor has partnered with the Dutch biotechnology companies HUB Organoids and MIMETAS. These companies will present their collaborative research and projects that leverage the capabilities of Yamaha’s CELL HANDLER™ 2. Yamaha’s participation will also include a product introduction presentation by a member of its development team on Tuesday, January 28, at 5:30 PM local time.
The cell handler 2 is set for release in March 2025 and is designed to streamline various stages of cell research, from suction and dispensing to observation, analysis, and handling. This innovative system aims to significantly improve the efficiency and accuracy of cell-related experiments, contributing to advancements in new drug development and regenerative medicine.
Yamaha Motor has identified the medical and healthcare industries as key areas for growth and is committed to expanding its role in this sector. The company envisions the CELL HANDLER 2 as a cornerstone product in its strategy to establish a future core business in medical technology and healthcare automation.